Anti-Cytokeratin 19 reacts with a wide variety of epithelium and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although, follicular carcinoma is also labeled by this antibody approximately 50-60% of the time.
|0.1 ml concentrated||319M-14|
|0.5 ml concentrated||319M-15|
|1 ml concentrated||319M-16|
|1 ml prediluted||319M-17|
|7 ml prediluted||319M-18|
|5 Positive Control Slides ||319S|
||Instructions for Use
Note: Research Use Only (RUO) datasheets
are not available online. Please contact customer service to request a datasheet.